Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Angiogenesis Assays Market to reach USD XX million by 2028.

Global Angiogenesis Assays Market Size study, By Product Type (Angiogenesis Tube Formation Assays, Microfluidic Angiogenesis Assays, Endothelial Adhesion, Invasion and Migration Assays), By Application (In Vitro Angiogenesis, In Vivo Angiogenesis), By End User (Angiogenesis Assays for Hospitals, Angiogenesis Assays for Specialty Clinics, Angiogenesis Assays for Ambulatory Surgical Centers), and Regional Forecasts 2022-2028

Product Code: HLSB-13395762
Publish Date: 12-07-2022
Page: 200

Global Angiogenesis Assays Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Angiogenesis refers to the process of generating new capillary blood vessels. It is essential for the delivery of oxygen and nutrients to the body’s tissues. Angiogenesis is stimulated when tumor tissues require nutrients and oxygen. This abnormal blood vessel growth can be the underlying cause of many deadly and debilitating diseases including cancer, cardiovascular disease, stroke, and diabetic and age-related blindness. angiogenesis assays are utilized to analyze new blood vessel formation for applications of cancer research, tissue regeneration and vascular biology. The rising incidences of cancer disease worldwide and increasing number cancer research investments as well as recent funding activities are factors that are accelerating the global market demand. For instance, according to World Cancer Research Fund International – in 2020, globally total number of cancer cases were estimated at 18.1 million. Out of these around 9.3 million cases were in men and around 8.8 million were in women. Breast and lung cancers were estimated as the most prevalent cancer type worldwide, accounting for 12.5% (2,261,419) and 12.2% (2,206,771) of the total number of new cases diagnosed in 2020. Furthermore, recent funding activities from public sector authorities would influence the growth of Angiogenesis Market. For instance, in January 2022, The Cancer Research UK center granted USD 11.20 million to University of Oxford and the Oxford-based NHS to fund cancer research. Additional USD 3.05 million grant would be intended for training and studentships over the next five years. Also, growing healthcare infrastructure in emerging economies and increasing prevalence of chronic diseases are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, a lack of technical expertise in developing regions coupled with high cost associated with cancer research impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Angiogenesis Assays Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of funding activities towards cancer research and presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising incidences of chronic disease and rising healthcare spending in the region, would create lucrative growth prospects for the global Angiogenesis Assays Market across the Asia Pacific region.

Major market players included in this report are:
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Angiogenesis Tube Formation Assays
Microfluidic Angiogenesis Assays
Endothelial Adhesion
Invasion and Migration Assays
By Application:
In Vitro Angiogenesis
In Vivo Angiogenesis
By End User:
Angiogenesis Assays for Hospitals
Angiogenesis Assays for Specialty Clinics
Angiogenesis Assays for Ambulatory Surgical Centers
By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Angiogenesis Assays Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Angiogenesis Assays Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Angiogenesis Assays Market, by Product Type, 2020-2028 (USD Million)
1.2.3. Global Angiogenesis Assays Market, by Application, 2020-2028 (USD Million)
1.2.4. Global Angiogenesis Assays Market, by End User, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Angiogenesis Assays Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Angiogenesis Assays Market Dynamics
3.1. Angiogenesis Assays Market Impact Analysis (2020-2028)
3.1.1. Market Drivers Rising incidences of cancer disease worldwide. Increasing number cancer research investments. Recent funding activities.
3.1.2. Market Challenges Lack of technical expertise in developing regions. High cost associated with cancer research.
3.1.3. Market Opportunities Growing healthcare infrastructure in emerging economies. Increasing prevalence of chronic diseases.
Chapter 4. Global Angiogenesis Assays Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Angiogenesis Assays Market, by Product Type
6.1. Market Snapshot
6.2. Global Angiogenesis Assays Market by Product Type, Performance – Potential Analysis
6.3. Global Angiogenesis Assays Market Estimates & Forecasts by Product Type 2018-2028 (USD Million)
6.4. Angiogenesis Assays Market, Sub Segment Analysis
6.4.1. Angiogenesis Tube Formation Assays
6.4.2. Microfluidic Angiogenesis Assays
6.4.3. Endothelial Adhesion
6.4.4. Invasion and Migration Assays
Chapter 7. Global Angiogenesis Assays Market, by Application
7.1. Market Snapshot
7.2. Global Angiogenesis Assays Market by Application, Performance – Potential Analysis
7.3. Global Angiogenesis Assays Market Estimates & Forecasts by Application 2018-2028 (USD Million)
7.4. Angiogenesis Assays Market, Sub Segment Analysis
7.4.1. In Vitro Angiogenesis
7.4.2. In Vivo Angiogenesis
Chapter 8. Global Angiogenesis Assays Market, by End User
8.1. Market Snapshot
8.2. Global Angiogenesis Assays Market by End User, Performance – Potential Analysis
8.3. Global Angiogenesis Assays Market Estimates & Forecasts by End User 2018-2028 (USD Million)
8.4. Angiogenesis Assays Market, Sub Segment Analysis
8.4.1. Angiogenesis Assays for Hospitals
8.4.2. Angiogenesis Assays for Specialty Clinics
8.4.3. Angiogenesis Assays for Ambulatory Surgical Centers
Chapter 9. Global Angiogenesis Assays Market, Regional Analysis
9.1. Angiogenesis Assays Market, Regional Market Snapshot
9.2. North America Angiogenesis Assays Market
9.2.1. U.S. Angiogenesis Assays Market Product Type estimates & forecasts, 2018-2028 Application estimates & forecasts, 2018-2028 End User estimates & forecasts, 2018-2028
9.2.2. Canada Angiogenesis Assays Market
9.3. Europe Angiogenesis Assays Market Snapshot
9.3.1. U.K. Angiogenesis Assays Market
9.3.2. Germany Angiogenesis Assays Market
9.3.3. France Angiogenesis Assays Market
9.3.4. Spain Angiogenesis Assays Market
9.3.5. Italy Angiogenesis Assays Market
9.3.6. Rest of Europe Angiogenesis Assays Market
9.4. Asia-Pacific Angiogenesis Assays Market Snapshot
9.4.1. China Angiogenesis Assays Market
9.4.2. India Angiogenesis Assays Market
9.4.3. Japan Angiogenesis Assays Market
9.4.4. Australia Angiogenesis Assays Market
9.4.5. South Korea Angiogenesis Assays Market
9.4.6. Rest of Asia Pacific Angiogenesis Assays Market
9.5. Latin America Angiogenesis Assays Market Snapshot
9.5.1. Brazil Angiogenesis Assays Market
9.5.2. Mexico Angiogenesis Assays Market
9.6. Rest of The World Angiogenesis Assays Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abcam Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.2.2. Bio-Techne
10.2.3. Thermo Fisher Scientific
10.2.4. Cell Biolabs, Inc.
10.2.5. BioVision, Inc
10.2.6. PromoCell GmbH
10.2.7. Merck KGaA
10.2.8. Kollodis BioSciences
10.2.9. Sartorius (Essen BioScience)
10.2.10. Creative Bioarray
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now